Literature DB >> 17640567

Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane).

Santosh K Sandur1, Haruyo Ichikawa, Manoj K Pandey, Ajaikumar B Kunnumakkara, Bokyung Sung, Gautam Sethi, Bharat B Aggarwal.   

Abstract

Extensive research within the past half-century has indicated that curcumin (diferuloylmethane), a yellow pigment in curry powder, exhibits antioxidant, anti-inflammatory, and proapoptotic activities. We investigated whether the anti-inflammatory and proapoptotic activities assigned to curcumin are mediated through its prooxidant/antioxidant mechanism. We found that TNF-mediated NF-kappaB activation was inhibited by curcumin; and glutathione reversed the inhibition. Similarly, suppression of TNF-induced AKT activation by curcumin was also abrogated by glutathione. The reducing agent also counteracted the inhibitory effects of curcumin on TNF-induced NF-kappaB-regulated antiapoptotic (Bcl-2, Bcl-xL, IAP1), proliferative (cyclin D1), and proinflammatory (COX-2, iNOS, and MMP-9) gene products. The suppression of TNF-induced AP-1 activation by curcumin was also reversed by glutathione. Also, the direct proapoptotic effects of curcumin were inhibited by glutathione and potentiated by depletion of intracellular glutathione by buthionine sulfoximine. Moreover, curcumin induced the production of reactive oxygen species and modulated intracellular GSH levels. Quenchers of hydroxyl radicals, however, were ineffective in inhibiting curcumin-mediated NF-kappaB suppression. Further, N-acetylcysteine partially reversed the effect of curcumin. Based on these results we conclude that curcumin mediates its apoptotic and anti-inflammatory activities through modulation of the redox status of the cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640567      PMCID: PMC2754304          DOI: 10.1016/j.freeradbiomed.2007.05.009

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  65 in total

1.  EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism.

Authors:  Brian K Adams; Jiyang Cai; Jeff Armstrong; Marike Herold; Yang J Lu; Aiming Sun; James P Snyder; Dennis C Liotta; Dean P Jones; Mamoru Shoji
Journal:  Anticancer Drugs       Date:  2005-03       Impact factor: 2.248

2.  Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates.

Authors:  S Bhaumik; R Anjum; N Rangaraj; B V Pardhasaradhi; A Khar
Journal:  FEBS Lett       Date:  1999-08-06       Impact factor: 4.124

3.  Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity.

Authors:  Saibal K Biswas; Danny McClure; Luis A Jimenez; Ian L Megson; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2005 Jan-Feb       Impact factor: 8.401

4.  Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons.

Authors:  M Tamatani; Y H Che; H Matsuzaki; S Ogawa; H Okado; S Miyake; T Mizuno; M Tohyama
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

5.  Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells.

Authors:  F Zhang; N K Altorki; J R Mestre; K Subbaramaiah; A J Dannenberg
Journal:  Carcinogenesis       Date:  1999-03       Impact factor: 4.944

6.  NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.

Authors:  O N Ozes; L D Mayo; J A Gustin; S R Pfeffer; L M Pfeffer; D B Donner
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

7.  Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells.

Authors:  Jie Chen; Da Wanming; Dawei Zhang; Qing Liu; Jiuhong Kang
Journal:  Pharmazie       Date:  2005-01       Impact factor: 1.267

8.  Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells.

Authors:  A Khar; A M Ali; B V Pardhasaradhi; Z Begum; R Anjum
Journal:  FEBS Lett       Date:  1999-02-19       Impact factor: 4.124

9.  In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties.

Authors:  M M Chan; H I Huang; M R Fenton; D Fong
Journal:  Biochem Pharmacol       Date:  1998-06-15       Impact factor: 5.858

10.  Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis.

Authors:  Yasunari Takada; Fadlo R Khuri; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2004-04-16       Impact factor: 5.157

View more
  82 in total

1.  Protective effect of curcumin and its combination with piperine (bioavailability enhancer) against haloperidol-associated neurotoxicity: cellular and neurochemical evidence.

Authors:  Mahendra Bishnoi; Kanwaljit Chopra; Lu Rongzhu; Shrinivas K Kulkarni
Journal:  Neurotox Res       Date:  2010-11-13       Impact factor: 3.911

2.  Curcumin induces differentiation of embryonic stem cells through possible modulation of nitric oxide-cyclic GMP pathway.

Authors:  Kalpana Mujoo; Lubov E Nikonoff; Vladislav G Sharin; Nathan S Bryan; Alexander Y Kots; Ferid Murad
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

3.  Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease.

Authors:  Zakiya Qualls; Dwayne Brown; Carlana Ramlochansingh; Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2014-01       Impact factor: 3.911

4.  Combination Therapy with Curcumin Alone Plus Piperine Ameliorates Ovalbumin-Induced Chronic Asthma in Mice.

Authors:  Preeti S Chauhan; Anju Jaiswal; Rashmi Singh
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

5.  Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.

Authors:  M Montopoli; E Ragazzi; G Froldi; L Caparrotta
Journal:  Cell Prolif       Date:  2009-02-18       Impact factor: 6.831

6.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.

Authors:  Ji Wang; Chunying Wang; Gaofeng Bu
Journal:  Exp Ther Med       Date:  2018-01-29       Impact factor: 2.447

Review 7.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

Review 8.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 9.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

10.  Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression.

Authors:  Dan Feng; Lena Ohlsson; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2010-04-19       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.